alterations, such as karyotypic abnormalities and N-RAS and Tf53 mutations.2" are closely associated with the development and subseMicrosatellite instability (MSI), considered to represent the defect quent progression of the disease. However, many MDS patients show
o f D N A mismatch repair mechanisms, has been shown to take part disease progression without any known genetic events, thus other in the tumorigenesis of several human malignancies.' Although MS1
genetic alterations are likely to contribute to disease progression.
was recently reported to be associated with the blast crisis of chronic
We examined four microsatellites located on chromosome 8p myelogenous leukemia,' it has not been examined in other hemato-(AFM198wd2): 9p (AFM186xc3); 17p (TPS3CA)," l 8 q ( W C ) * in logic disorders. In myelodysplastic syndrome (MDS), several genetic six MDS patients in relation to the development and the progression For (Table l) . Genomic DNA extr-acted from bone marrow cells was amplified for these microsatellites using polymerase chain reaction in the presence of 2 pCi of [a-"SIdATP as described7 and compared with constitutional DNA extracted from bone marrOw fibroblasts. In all patients, marrow cells were obtained at two or more occasions during their disease course, and the amplified prvducts of each sample including fibroblast DNA were electrophoresed on the same denaturing gel. MS1 was characterized as a difference of band pattern.
Bone marrow DNA of cases l and 3 showed MS1 at all the four loci examined when compared with corresponding fibroblast DNAs, whereas no more alteration was observed among marrow DNA samples obtained after various intervals (3 and I1 months in case 1 and 7 in case 3) (Fig  1 and Table 1 ). In case 3, loss of heterozygosity at AFMl86xc3 was also seen. These two cases did not show disease progression to more advanced subtypes during the intewals. On the other hand, MS1 was not detected at any locus in the remaining cases even after the leukemic transformation in case 4 (Fig l) . These results suggest that MS1 appears to contribute to the pathogenesis of MDS in some patients, especially as an early genetic event. This is consistent with previous reports on colorectal cancer, where MS1 is associated with a longer survival8 and is already been detected in adenomatous tissue adjacent to cancer." Another interesting finding is that MS1 occurs independently from chromosome findings and N-RAS and TP53 configurations in this small series of patients; abnormal karyotype in cases I , 4, 5, and 6 ( 
